New skin cancer medicine now approved in the EU for adults with metastatic or locally advanced cutaneous squamous cell carcinoma.
approvals
-
Read more »
-
October 03, 2018
-
November 17, 2017Read more »
We talk to Sera, our Medicines Sourcing Manager about why drug delays happen...
-
March 18, 2016Read more »
The FDA approval of a promising new drug is offering new hope to multiple myeloma patients who have already been through various treatments.
